TTS Pharma was incorporated in late 2012 to acquire various drug delivery and diagnostic /pharmacogenetic technologies. The Company has since acquired, developed and validated processes and technologies to extract, separate and trace the bulk active ingredients found in Industrial Hemp that can be converted into finished products. All our products offer a traceable supply chain from ‘crop to shop’.
The Company is focused on providing Cannabinoid components, such as CBD, into the Wellness and Unlicensed markets. We also participate in, and sponsor, a number of early stage research projects in anticipation that in future we can develop licensed pharmaceutical products through our three core drug delivery platforms using Transdermal, Oral and Inhaler technologies.